<?xml version='1.0' encoding='utf-8'?>
<document id="19440845"><sentence text="Structure-based prediction of the nonspecific binding of drugs to hepatic microsomes." /><sentence text="For the accurate prediction of in vivo hepatic clearance or drug-drug interaction potential through in vitro microsomal metabolic data, it is essential to evaluate the fraction unbound in hepatic microsomal incubation media" /><sentence text=" Here, a structure-based in silico predictive model of the nonspecific binding (fu(mic), fraction unbound in hepatic microsomes) for 86 drugs was successfully developed based on seven selected molecular descriptors" /><sentence text=" The R(2) of the predicted and observed log((1 - fu(mic))/fu(mic)) for the training set (n = 64) and test set (n = 22) were 0" /><sentence text="82 and 0" /><sentence text="85, respectively" /><sentence text=" The average fold error (AFE, calculated by fu(mic) rather than log((1 - fu(mic))/fu(mic))) of the in silico model was 1" /><sentence text="33 (n = 86)" /><sentence text=" The predictive capability of fu(mic) for neutral drugs compared well to that for basic compounds (R(2) = 0" /><sentence text="82, AFE = 1" /><sentence text="18 and fold error values were all below 2, except for felodipine and progesterone) in our model"><entity charOffset="54-64" id="DDI-PubMed.19440845.s11.e0" text="felodipine" /><entity charOffset="69-81" id="DDI-PubMed.19440845.s11.e1" text="progesterone" /><pair ddi="false" e1="DDI-PubMed.19440845.s11.e0" e2="DDI-PubMed.19440845.s11.e0" /><pair ddi="false" e1="DDI-PubMed.19440845.s11.e0" e2="DDI-PubMed.19440845.s11.e1" /></sentence><sentence text=" This model appears to perform better for neutral compounds when compared to models previously published in the literature" /><sentence text=" Therefore, this in silico model may be used as an additional tool to estimate fu(mic) and for predicting in vivo hepatic clearance and inhibition potential from in vitro hepatic microsomal studies" /><sentence text="" /></document>